Exact Mass: 335.173264

Exact Mass Matches: 335.173264

Found 500 metabolites which its exact mass value is equals to given mass value 335.173264, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Senecionine

(1,6)Dioxacyclododecino(2,3,4-gh)pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-, (3Z,5R,6R,14aR,14bR)-

C18H25NO5 (335.173264)


Senecionine is a pyrrolizidine alkaloid isolated from the plant species of the genus Senecio. It has a role as a plant metabolite. It is a lactone, a pyrrolizidine alkaloid and a tertiary alcohol. It is functionally related to a senecionan. It is a conjugate base of a senecionine(1+). Senecionine is a natural product found in Dorobaea pimpinellifolia, Crotalaria micans, and other organisms with data available. Senecionine is an organic compound with the chemical formula C18H25NO5. It is classified as a pyrrolizidine alkaloid. See also: Petasites hybridus root (part of); Tussilago farfara flower (part of); Tussilago farfara leaf (part of). A pyrrolizidine alkaloid isolated from the plant species of the genus Senecio. D000970 - Antineoplastic Agents Annotation level-1 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2251 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 122 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 102 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 142 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 152 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 162 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 172 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 132 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 112 [Raw Data] CB082a_Senecionine_pos_40eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_10eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_30eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_20eV_CB000034.txt [Raw Data] CB082a_Senecionine_pos_50eV_CB000034.txt Senecionine (Senecionan-11,16-dione, 12-hydroxy-) is a pyrrolizidine alkaloid could be isolated from Senecio vulgaris. Senecionine decreases the activities of glutathione S-transferase, aminopyrine demethylase and arylhydrocarbon hydroxylase (AHH)[1][2][3]. Senecionine (Senecionan-11,16-dione, 12-hydroxy-) is a pyrrolizidine alkaloid could be isolated from Senecio vulgaris. Senecionine decreases the activities of glutathione S-transferase, aminopyrine demethylase and arylhydrocarbon hydroxylase (AHH)[1][2][3].

   

N-acetylglucosaminylasparagine

(2S)-2-amino-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl}propanoic acid

C12H21N3O8 (335.1328586)


Aspartylglycosamine, also known as n4-(beta-N-acetyl-D-glucosaminyl)-L-asparagine or 1-beta-aspartyl-N-acetyl-D-glucosaminylamine, is a member of the class of compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Aspartylglycosamine is soluble (in water) and a moderately acidic compound (based on its pKa). Aspartylglycosamine can be found primarily in urine, as well as in human spleen tissue. Within the cell, aspartylglycosamine is primarily located in the cytoplasm. Moreover, aspartylglycosamine is found to be associated with aspartylglucosaminuria, which is an inborn error of metabolism. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria corresponding to decreased activity of aspartylglycosamine amido hydrolase. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria, which is a metabolic disorder associated with decreased activity of aspartylglycosamine amido hydrolase. [HMDB]

   

isopentenyl adenosine

(2R,3S,4R,5R)-2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol

C15H21N5O4 (335.15934660000005)


Riboprine, also known as isopentenyladenosine or ipa, is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Riboprine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Riboprine can be found in a number of food items such as peppermint, chinese mustard, custard apple, and green bean, which makes riboprine a potential biomarker for the consumption of these food products. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins Acquisition and generation of the data is financially supported in part by CREST/JST. Same as: D05726 N6-Isopentenyladenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-Isopentenyladenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity[1][2][3].

   

Hydroxychloroquine

7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline

C18H26ClN3O (335.1764296)


Hydroxychloroquine is only found in individuals that have used or taken this drug. It is a chemotherapeutic agent that acts against erythrocytic forms of malarial parasites.Although the exact mechanism of action is unknown, it may be based on ability of hydroxychloroquine to bind to and alter DNA. Hydroxychloroquine has also has been found to be taken up into the acidic food vacuoles of the parasite in the erythrocyte. This increases the pH of the acid vesicles, interfering with vesicle functions and possibly inhibiting phospholipid metabolism. In suppressive treatment, hydroxychloroquine inhibits the erythrocytic stage of development of plasmodia. In acute attacks of malaria, it interrupts erythrocytic schizogony of the parasite. Its ability to concentrate in parasitized erythrocytes may account for their selective toxicity against the erythrocytic stages of plasmodial infection. As an antirheumatic, hydroxychloroquine is thought to act as a mild immunosuppressant, inhibiting the production of rheumatoid factor and acute phase reactants. It also accumulates in white blood cells, stabilizing lysosomal membranes and inhibiting the activity of many enzymes, including collagenase and the proteases that cause cartilage breakdown. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Senecivernine

21-Norsenecionan-11,16-dione, 12-hydroxy-14-methyl-, (12zeta,13zeta)-

C18H25NO5 (335.173264)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2276

   

Naratriptan

1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride

C17H25N3O2S (335.166739)


Naratriptan is only found in individuals that have used or taken this drug. It is a triptan drug used for the treatment of migraine headaches. It is a selective 5-hydroxytryptamine1 receptor subtype agonist.Three distinct pharmacological actions have been implicated in the antimigraine effect of the triptans: (1) stimulation of presynaptic 5-HT1D receptors, which serves to inhibit both dural vasodilation and inflammation; (2) direct inhibition of trigeminal nuclei cell excitability via 5-HT1B/1D receptor agonism in the brainstem and (3) vasoconstriction of meningeal, dural, cerebral or pial vessels as a result of vascular 5-HT1B receptor agonism. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

Ankorine

Ankorine

C19H29NO4 (335.20964740000005)


A pyridoisoquinoline that is 1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline which is substituted at positions 2, 3, and 8 by 2-hydroxyethyl, ethyl, and hydroxy groups, respectively, and by methoxy groups at positions 9 and 10 (the 2R,3R,11bS stereoisomer). It is a benzo[a]quinolizidine alkaloid isolated from the Indian medicinal plant Alangium lamarckii.

   

Triangularine

6-Angelyl-9-sarracinylretronecine

C18H25NO5 (335.173264)


   

(+)-Validoxylamine-A

(1S,2S,3R,6S)-4-(hydroxymethyl)-6-[[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino]cyclohex-4-ene-1,2,3-triol

C14H25NO8 (335.158009)


An amino cyclitol that is (1R,2S,3S,4S,6R)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol in which one of the hydrogens attached to the nitrogen is replaced by a (1R,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl group. Validoxylamine A is an amino cyclitol that is (1R,2S,3S,4S,6R)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol in which one of the hydrogens attached to the nitrogen is replaced by a (1R,4R,5R,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl group. It has a role as an EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor, a bacterial metabolite, an antibiotic insecticide and an animal metabolite. It is an amino cyclitol and a secondary amino compound. It is functionally related to a validamine. It is a conjugate base of a validoxylamine A(1+). Validoxylamine A is a natural product found in Apis ceran

   

Lobelanine

2-[(2S,6R)-1-methyl-6-(2-oxo-2-phenyl-ethyl)piperidin-2-yl]-1-phenyl-ethanone

C22H25NO2 (335.188519)


Lobelanine is a member of acetophenones. Lobelanine is a natural product found in Lobelia sessilifolia, Lobelia inflata, and other organisms with data available. Lobelanine (8,10-Diphenyllobelidione) is a chemical precursor for the biosynthesis of Lobeline. Lobeline is a partial nicotinic agonist and is used as a smoking cessation agent[1][2]. Lobelanine (8,10-Diphenyllobelidione) is a chemical precursor for the biosynthesis of Lobeline. Lobeline is a partial nicotinic agonist and is used as a smoking cessation agent[1][2].

   

Cetrimide

Tetradecyl trimethyl ammonium bromide

C17H38N. Br (335.2187448)


Same as: D02164

   

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

(Z,2Z)-N-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylpropa-2-enimidic acid

C22H25NO2 (335.188519)


N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide is found in fruits. N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide is an alkaloid from the leaves of Aegle marmelos (bael fruit

   

Almotriptan

dimethyl(2-{5-[(pyrrolidine-1-sulfonyl)methyl]-1H-indol-3-yl}ethyl)amine

C17H25N3O2S (335.166739)


Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Almotriptan does not prevent migraine attacks. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Almotriptan is a selective agonist of 5-HT 1B/1D Receptor. Almotriptan can used in study of migraine attacks[1].

   

Tryptophyl-Methionine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-4-(methylsulphanyl)butanoic acid

C16H21N3O3S (335.13035560000003)


Tryptophyl-Methionine is a dipeptide composed of tryptophan and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Methionyl-Tryptophan

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.13035560000003)


Methionyl-Tryptophan is a dipeptide composed of methionine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

[(4Z,6E,10Z,13Z)-1-carboxynonadeca-4,6,10,13-tetraen-8-yl]peroxy

C20H31O4 (335.2222226)


This compound belongs to the family of Hydroperoxy Fatty Acids. These are fatty acids contaning a hydroperoxide group attached to the chain.

   

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

[(4Z,7Z,11E,13Z)-1-carboxynonadeca-4,7,11,13-tetraen-10-yl]peroxy

C20H31O4 (335.2222226)


This compound belongs to the family of Hydroperoxy Fatty Acids. These are fatty acids contaning a hydroperoxide group attached to the chain.

   

Integerrimine

4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   

N6-Cyclopentyladenosine

2-[6-(cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O4 (335.15934660000005)


   

25C-NBOMe

2-(4-Chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine

C18H22ClNO3 (335.1288132000001)


   

2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone

2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

C22H25NO2 (335.188519)


   

Acarviosin

6-[(4,5-dihydroxy-6-methoxy-2-methyloxan-3-yl)amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol

C14H25NO8 (335.158009)


   

Alkaloid A

{1-[(2-methylbut-2-enoyl)oxy]-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl}methyl 2-(hydroxymethyl)but-2-enoic acid

C18H25NO5 (335.173264)


   

Cloquintocet-mexyl

1-Methylhexyl 2-[(5-chloro-8-quinolinyl)oxy]acetic acid

C18H22ClNO3 (335.1288132000001)


   

Dansylcadaverine

N-(5-aminopentyl)-5-(dimethylamino)naphthalene-1-sulfonamide

C17H25N3O2S (335.166739)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

Diethylenetriaminetetraacetic acid

2-{[2-({2-[bis(carboxymethyl)amino]ethyl}amino)ethyl](carboxymethyl)amino}acetic acid

C12H21N3O8 (335.1328586)


   

Hippuryl-L-arginine

5-[(diaminomethylidene)amino]-2-[2-(phenylformamido)acetamido]pentanoic acid

C15H21N5O4 (335.15934660000005)


   

Ramixotidine

N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulphanyl]ethyl}-1-oxo-1-pyridine-3-carboximidic acid

C16H21N3O3S (335.13035560000003)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

   

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

C22H25NO2 (335.188519)


   

Riboprine

2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol

C15H21N5O4 (335.15934660000005)


   

2-(4-(Benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine

2-(5-Benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride

C20H21N3O2 (335.1633686)


   

3-[(2-Aminoethylamino)methyl]-3-[bis(carboxymethyl)amino]pentanedioic acid

3-{[(2-aminoethyl)amino]methyl}-3-[bis(carboxymethyl)amino]pentanedioic acid

C12H21N3O8 (335.1328586)


   

Tubastatin A

N-Hydroxy-4-[(2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)methyl]benzamide

C20H21N3O2 (335.1633686)


   

N-6-Isopent-2-enyl-adenosine

(2S,3R,4S,5S)-2-(hydroxymethyl)-5-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolane-3,4-diol

C15H21N5O4 (335.15934660000005)


N-6-isopent-2-enyl-adenosine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). N-6-isopent-2-enyl-adenosine can be found in wild celery, which makes N-6-isopent-2-enyl-adenosine a potential biomarker for the consumption of this food product.

   
   
   

7,8-Dimethoxymyrtopsine

(+)-7,8-Dimethoxymyrtopsine

C17H21NO6 (335.13688060000004)


   

Pyrrolo[2,1-b]quinazolin-9(1H)-one, 3-[o-(dimethylamino)phenyl]-2,3-dihydro-5-methoxy-

Pyrrolo[2,1-b]quinazolin-9(1H)-one, 3-[o-(dimethylamino)phenyl]-2,3-dihydro-5-methoxy-

C20H21N3O2 (335.1633686)


   
   
   
   

Rigidiusculamide D

Rigidiusculamide D

C18H25NO5 (335.173264)


   
   
   
   
   
   
   

Cloquintocet-mexyl

Cloquintocet-mexyl

C18H22ClNO3 (335.1288132000001)


CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10219; ORIGINAL_PRECURSOR_SCAN_NO 10218 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10248; ORIGINAL_PRECURSOR_SCAN_NO 10246 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10275; ORIGINAL_PRECURSOR_SCAN_NO 10273 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10288; ORIGINAL_PRECURSOR_SCAN_NO 10286 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10259; ORIGINAL_PRECURSOR_SCAN_NO 10258 CONFIDENCE standard compound; INTERNAL_ID 286; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10304; ORIGINAL_PRECURSOR_SCAN_NO 10302

   

JWH-250

2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone

C22H25NO2 (335.188519)


   
   
   
   
   
   

MBP146-78

Pyridine, 4-[2-(4-fluorophenyl)-5-(1-methyl-4-piperidinyl)-1H-pyrrol-3-yl]-

C21H22FN3 (335.1797664)


   
   
   
   

3-Deoxy-3-methylaminoxylose-1,2-O-Isopropylidene, N-Ac, 5-benzyl

3-Deoxy-3-methylaminoxylose-1,2-O-Isopropylidene, N-Ac, 5-benzyl

C18H25NO5 (335.173264)


   

3-ethyl-2-(2-hydroxy-ethyl)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-11-ol|Ankorin

3-ethyl-2-(2-hydroxy-ethyl)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-11-ol|Ankorin

C19H29NO4 (335.20964740000005)


   

hydroxymethylmycophenolic acid amide

hydroxymethylmycophenolic acid amide

C17H21NO6 (335.13688060000004)


   

7-Senecioyl-9-sarracinoyl retronecine|7-senecioyl-9-sarracinylretronecine

7-Senecioyl-9-sarracinoyl retronecine|7-senecioyl-9-sarracinylretronecine

C18H25NO5 (335.173264)


   
   
   
   

Perforine

Perforine

C18H25NO5 (335.173264)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids; Origin: Plant

   
   

convolinine|N-hydroxyethylconvolvine

convolinine|N-hydroxyethylconvolvine

C18H25NO5 (335.173264)


   
   

11-hydroxy-4,12-dimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

11-hydroxy-4,12-dimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C19H29NO2S (335.19188940000004)


   
   

2,3-O-Isopropylidene-N-Dimethyladenosine

2,3-O-Isopropylidene-N-Dimethyladenosine

C15H21N5O4 (335.15934660000005)


   

3-[[2-Carboxy-2-(acetylamino)ethyl]thio]-4-hydroxynonanoic acid

3-[[2-Carboxy-2-(acetylamino)ethyl]thio]-4-hydroxynonanoic acid

C14H25NO6S (335.14025100000003)


   
   
   
   

3-Phenyl-5-(3-methyl-2-butenyl)-6-methoxy-8-hydroxyisoquinoline-1(2H)-one

3-Phenyl-5-(3-methyl-2-butenyl)-6-methoxy-8-hydroxyisoquinoline-1(2H)-one

C21H21NO3 (335.15213560000007)


   

Cyclopiazonic acid imine

Cyclopiazonic acid imine

C20H21N3O2 (335.1633686)


   
   
   

4-Acetoxy-1,3,5,6-tetramethoxy-2-(N-methylacetylamino)hexane

4-Acetoxy-1,3,5,6-tetramethoxy-2-(N-methylacetylamino)hexane

C15H29NO7 (335.19439239999997)


   

2-(1-methyl-6-phenacylpiperidin-2-yl)-1-phenylethanone

2-(1-methyl-6-phenacylpiperidin-2-yl)-1-phenylethanone

C22H25NO2 (335.188519)


   
   

7-((S)-2,3-Dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]chinolin-8-on|7-((S)-2,3-dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Hydroxylunidin|Hydroxylunidine|Isoorixin|isoorixine

7-((S)-2,3-Dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]chinolin-8-on|7-((S)-2,3-dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Hydroxylunidin|Hydroxylunidine|Isoorixin|isoorixine

C17H21NO6 (335.13688060000004)


   

N3-Ac,N8-Me,10-deoxy-搂脦-(2-Hydroxy-4-oxodecanoyl)histidine

N3-Ac,N8-Me,10-deoxy-搂脦-(2-Hydroxy-4-oxodecanoyl)histidine

C18H29N3O3 (335.22088040000006)


   

2-Deoxyribosylzeatin|2-Deoxyzeatin 9-beta-D-ribofuranoside|2-deoxyzeatin riboside|6-(4-hydroxy-3-methylbut-trans-2-enylamino)-9-beta-2-deoxy-D-ribofuranosylpurine|9-(2-deoxy-beta-D-ribofuranosyl)-trans-zeatin|cytokinin

2-Deoxyribosylzeatin|2-Deoxyzeatin 9-beta-D-ribofuranoside|2-deoxyzeatin riboside|6-(4-hydroxy-3-methylbut-trans-2-enylamino)-9-beta-2-deoxy-D-ribofuranosylpurine|9-(2-deoxy-beta-D-ribofuranosyl)-trans-zeatin|cytokinin

C15H21N5O4 (335.15934660000005)


   

3alpha-hydroxy-6beta-(3-hydroxy-2-methyl-3-phenylpropionyloxy)-7beta-hydroxytropane

3alpha-hydroxy-6beta-(3-hydroxy-2-methyl-3-phenylpropionyloxy)-7beta-hydroxytropane

C18H25NO5 (335.173264)


   
   
   
   
   
   

Tubastatin A

N-hydroxy-4-((2H-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)methyl)benzamide

C20H21N3O2 (335.1633686)


   
   
   
   
   
   
   
   
   
   
   
   
   

Rev 5901

α-pentyl-3-(2-quinolinylmethoxy)-benzenemethanol

C22H25NO2 (335.188519)


   
   
   
   
   
   
   
   

Squalidin

(1,6)DIOXACYCLODODECINO(2,3,4-GH)PYRROLIZINE-2,7-DIONE, 3-ETHYLIDENE-3,4,5,6,9,11,13,14,14A,14B-DECAHYDRO-6-HYDROXY-5,6-DIMETHYL-, (3E,5R,6R,14AR,14BR)-

C18H25NO5 (335.173264)


Integerrimine is a macrolide. Integerrimine is a natural product found in Crotalaria micans, Tussilago farfara, and other organisms with data available. See also: Petasites hybridus root (part of). D000970 - Antineoplastic Agents

   

isopentenyl-Adenosine-[d6]

isopentenyl-Adenosine-[d6]

C15H21N5O4 (335.15934660000005)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Isopentenyl-Adenosine

Isopentenyl-Adenosine

C15H21N5O4 (335.15934660000005)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Isopentenyladenosine

N6-Isopentenyladenosine

C15H21N5O4 (335.15934660000005)


N6-Isopentenyladenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-Isopentenyladenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity[1][2][3].

   

(E)-methyl 11-(5-carbamoyl-4-oxo-4H-pyran-2-yl)undec-10-enoate_120105

(E)-methyl 11-(5-carbamoyl-4-oxo-4H-pyran-2-yl)undec-10-enoate_120105

C18H25NO5 (335.173264)


   

N6-Isopentenyladenosine

6-(gamma,gamma-Dimethylallylamino)purine riboside

C15H21N5O4 (335.15934660000005)


N6-Isopentenyladenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-Isopentenyladenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity[1][2][3].

   
   

Riboprine

Isopentenyladenine riboside

C15H21N5O4 (335.15934660000005)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins Same as: D05726 CONFIDENCE standard compound; INTERNAL_ID 306 N6-Isopentenyladenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-Isopentenyladenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity[1][2][3].

   

hydroxychloroquine

hydroxychloroquine

C18H26ClN3O (335.1764296)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BA - Aminoquinolines COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2741

   

3,N4-4-Oxo-2-hexenal-5-methyl-deoxycytidine

3,N4-4-Oxo-2-hexenal-5-methyl-deoxycytidine

C16H21N3O5 (335.1481136)


   
   
   
   
   
   
   
   
   
   
   
   
   

Almotriptan

Almotriptan

C17H25N3O2S (335.166739)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Almotriptan is a selective agonist of 5-HT 1B/1D Receptor. Almotriptan can used in study of migraine attacks[1].

   
   

JWH 201

2-(4-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone

C22H25NO2 (335.188519)


   
   

Met-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C16H21N3O3S (335.13035560000003)


A dipeptide formed from L-methionine and L-tryptophan residues.

   

TRP-Met

2-[2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.13035560000003)


   

N-Cinnamoyl-p-prenyloxyphenethylamine

(2Z)-N-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylprop-2-enamide

C22H25NO2 (335.188519)


   

CEHC glycine

N-(5-[(2R)-6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]-propanoyl)-glycine

C18H25NO5 (335.173264)


   

4-(4-nitrophenethyl)piperazine-1-carboxylic acid tert butyl ester

4-(4-nitrophenethyl)piperazine-1-carboxylic acid tert butyl ester

C17H25N3O4 (335.184497)


   

4-(4-nitrobenzylamino)piperidine-1-carboxylic acid tert-butyl ester

4-(4-nitrobenzylamino)piperidine-1-carboxylic acid tert-butyl ester

C17H25N3O4 (335.184497)


   

(4-BENZYLOXY-BENZYL)-HYDRAZINE

(4-BENZYLOXY-BENZYL)-HYDRAZINE

C17H25N3O4 (335.184497)


   

(3R,4S)-tert-Butyl 3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate

(3R,4S)-tert-Butyl 3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate

C18H25NO5 (335.173264)


   
   

2,3(1H)-ISOQUINOLINEDICARBOXYLIC ACID, 6-BORONO-3,4-DIHYDRO-, 2-(1,1-DIMETHYLETHYL) 3-METHYL ESTER

2,3(1H)-ISOQUINOLINEDICARBOXYLIC ACID, 6-BORONO-3,4-DIHYDRO-, 2-(1,1-DIMETHYLETHYL) 3-METHYL ESTER

C16H22BNO6 (335.1540102)


   
   

(2S,3S,4S)-2-METHYL-2-(CARBOXYCYCLOPROPYL)GLYCINE

(2S,3S,4S)-2-METHYL-2-(CARBOXYCYCLOPROPYL)GLYCINE

C18H25NO5 (335.173264)


   

3-(Benzyloxy)-2-(2-(benzyloxy)ethoxy)pyridine

3-(Benzyloxy)-2-(2-(benzyloxy)ethoxy)pyridine

C21H21NO3 (335.15213560000007)


   

2-N-BOC-8-METHOXY-2-METHYLAMINO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLICACID

2-N-BOC-8-METHOXY-2-METHYLAMINO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLICACID

C18H25NO5 (335.173264)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

C18H29N3O3 (335.22088040000006)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(4-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(4-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE

C18H29N3O3 (335.22088040000006)


   

(3S,4S)-BENZYL 3-AMINO-4-((TERT-BUTOXYCARBONYL)AMINO)PYRROLIDINE-1-CARBOXYLATE

(3S,4S)-BENZYL 3-AMINO-4-((TERT-BUTOXYCARBONYL)AMINO)PYRROLIDINE-1-CARBOXYLATE

C17H25N3O4 (335.184497)


   

panadiplon

panadiplon

C18H17N5O2 (335.1382182)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   
   

4-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]oxymethyl]benzoic acid

4-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]oxymethyl]benzoic acid

C18H25NO5 (335.173264)


   

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

C20H25N5 (335.210985)


   

Potassium tris(3,5-dimethyl-1-pyrazolyl)borate

Potassium tris(3,5-dimethyl-1-pyrazolyl)borate

C15H21BKN6 (335.15577360000003)


   
   

2-((tert-Butyldimethylsilyloxy)methyl)-6-(trimethylsilyl)furo[3,2-b]pyridine

2-((tert-Butyldimethylsilyloxy)methyl)-6-(trimethylsilyl)furo[3,2-b]pyridine

C17H29NO2Si2 (335.1736734)


   

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-{2-[(trimethylsilyl)oxy]propan-2-yl}pyridine

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-{2-[(trimethylsilyl)oxy]propan-2-yl}pyridine

C17H30BNO3Si (335.20878999999996)


   

3-BENZYLOXY-1-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTANECARBOXYLIC ACID

3-BENZYLOXY-1-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTANECARBOXYLIC ACID

C18H25NO5 (335.173264)


   

N,N,N-Tributyl-1-pentanaminium bromide

N,N,N-Tributyl-1-pentanaminium bromide

C17H38BrN (335.2187448)


   

2-(4-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO)BENZALDEHYDE

2-(4-[5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO)BENZALDEHYDE

C17H16F3N3O (335.1245402)


   

N6-Cyclopentyladenosine

N6-Cyclopentyladenosine

C15H21N5O4 (335.15934660000005)


N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively[1][2]. N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively[1][2].

   

(3R,4S)-1-tert-butoxycarbonyl-3-(2-ethoxyethoxy)-4-phenyl-2-azetidione

(3R,4S)-1-tert-butoxycarbonyl-3-(2-ethoxyethoxy)-4-phenyl-2-azetidione

C18H25NO5 (335.173264)


   

N-(ADAMANTAN-2-YL)-2-(NAPHTHALEN-2-YLOXY)ACETAMIDE

N-(ADAMANTAN-2-YL)-2-(NAPHTHALEN-2-YLOXY)ACETAMIDE

C22H25NO2 (335.188519)


   

(4-BENZYLOXY-3-METHOXY-BENZYL)-HYDRAZINE

(4-BENZYLOXY-3-METHOXY-BENZYL)-HYDRAZINE

C17H25N3O4 (335.184497)


   

1-BOC-4-(CARBOXY-PYRIDIN-4-YL-METHYL)-[1,4]DIAZEPANE

1-BOC-4-(CARBOXY-PYRIDIN-4-YL-METHYL)-[1,4]DIAZEPANE

C17H25N3O4 (335.184497)


   

1-[[2,4,6-Tris(isopropyl)phenyl]sulfonyl]-1H-1,2,4-triazole

1-[[2,4,6-Tris(isopropyl)phenyl]sulfonyl]-1H-1,2,4-triazole

C17H25N3O2S (335.166739)


   

azanium,2-methylidenehexanoic acid,2-methylprop-2-enoate,styrene

azanium,2-methylidenehexanoic acid,2-methylprop-2-enoate,styrene

C19H29NO4 (335.20964740000005)


   

1-BOC-4-(CARBOXY-PYRIDIN-3-YL-METHYL)-[1,4]DIAZEPANE

1-BOC-4-(CARBOXY-PYRIDIN-3-YL-METHYL)-[1,4]DIAZEPANE

C17H25N3O4 (335.184497)


   

3-BROMOBENZYLSULFONYLCHLORIDE

3-BROMOBENZYLSULFONYLCHLORIDE

C17H25N3O4 (335.184497)


   
   

N-[(2S)-1-Phenyl-2-propanyl]-L-lysinamide dihydrochloride

N-[(2S)-1-Phenyl-2-propanyl]-L-lysinamide dihydrochloride

C15H27Cl2N3O (335.1531072)


   

Benzoic acid,2-[[2-(phenylmethylene)heptylidene]amino]-, methyl ester

Benzoic acid,2-[[2-(phenylmethylene)heptylidene]amino]-, methyl ester

C22H25NO2 (335.188519)


   

N-(2,2-DIMETHOXY-ETHYL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

N-(2,2-DIMETHOXY-ETHYL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

C17H26BNO5 (335.1903936)


   

Nylidrin hydrochloride

Nylidrin hydrochloride

C19H26ClNO2 (335.1651966)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

SB505124

2-(4-(Benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine

C20H21N3O2 (335.1633686)


   

4-Chloro-6-methoxy-7-(3-piperidin-1-yl-propoxy)-quinazoline

4-Chloro-6-methoxy-7-(3-piperidin-1-yl-propoxy)-quinazoline

C17H22ClN3O2 (335.14004620000003)


   

1-(1-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

1-(1-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

C23H17N3 (335.1422402)


   

dl-leucyl-glycyl-dl-phenylalanine

dl-leucyl-glycyl-dl-phenylalanine

C17H25N3O4 (335.184497)


   

tert-butyl N-tert-butoxycarbonyl-n-(7h-purin-6-yl)carbamate

tert-butyl N-tert-butoxycarbonyl-n-(7h-purin-6-yl)carbamate

C15H21N5O4 (335.15934660000005)


   
   

3-phenyl-1-(6,7,8,9-tetrahydrobenzo[g][1,3]benzodioxol-6-ylmethyl)pyrrolidine

3-phenyl-1-(6,7,8,9-tetrahydrobenzo[g][1,3]benzodioxol-6-ylmethyl)pyrrolidine

C22H25NO2 (335.188519)


   

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-1- piperidinecarboxylate

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-1- piperidinecarboxylate

C17H22ClN3O2 (335.14004620000003)


   

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)-1- piperidinecarboxylate

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)-1- piperidinecarboxylate

C17H22ClN3O2 (335.14004620000003)


   

Boc-(S)-3-Amino-4-(4-tert-butylphenyl)butyric Acid

Boc-(S)-3-Amino-4-(4-tert-butylphenyl)butyric Acid

C19H29NO4 (335.20964740000005)


   
   

Methyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2 -yl}butanoate

Methyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2 -yl}butanoate

C17H25N3O4 (335.184497)


   

azanium,butyl prop-2-enoate,2-methylprop-2-enoate,styrene

azanium,butyl prop-2-enoate,2-methylprop-2-enoate,styrene

C19H29NO4 (335.20964740000005)


   

1-Benzyl-4-(3-trifuoromethyl)phenyl-4-piperdinol

1-Benzyl-4-(3-trifuoromethyl)phenyl-4-piperdinol

C19H20F3NO (335.14969060000004)


   

Isoetharine mesylate

4-[1-HYDROXY-2-([1-METHYLETHYL]AMINO)BUTYL]-1,2-BENZENEDIOL METHANESULFONATE

C14H25NO6S (335.14025100000003)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Isoetharine (Isoetarine) mesylate is an orally active selective agonist of β-adrenergic receptors. Isoetharine mesylate is a catechol-like agent and catechol O-methyltransferase (COMT) mediates its methylation. Isoetharine mesylate can promote the production of cAMP which stimulates the relaxation of smooth muscle cells and can be used as an emphysema, bronchitis and bronchodilator[1][2].

   

4-(5-ETHOXYCARBONYL-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(5-ETHOXYCARBONYL-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H25N3O4 (335.184497)


   

tert-butyl 6-fluoro-4-oxospiro[3H-chromene-2,4-piperidine]-1-carboxylate

tert-butyl 6-fluoro-4-oxospiro[3H-chromene-2,4-piperidine]-1-carboxylate

C18H22FNO4 (335.15327840000003)


   

tert-Butyl 4-(2-nitrobenzylamino)piperidine-1-carboxylate

tert-Butyl 4-(2-nitrobenzylamino)piperidine-1-carboxylate

C17H25N3O4 (335.184497)


   
   

2C-C-NBOMe

N-(2-methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

C18H22ClNO3 (335.1288132000001)


   
   

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

C21H18FNO2 (335.13214999999997)


   
   

Ontazolast

N-[(1S)-2-Cyclohexyl-1-(2-pyridinyl)ethyl]-5-methyl-1,3-benzoxazo l-2-amine

C21H25N3O (335.199752)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

   

Benzeneacetic acid, a-hydroxy-a-phenyl-, 2-(dimethylamino)ethylester, hydrochloride (9CI)

Benzeneacetic acid, a-hydroxy-a-phenyl-, 2-(dimethylamino)ethylester, hydrochloride (9CI)

C18H22ClNO3 (335.1288132000001)


   

1-[3,4-Bis(benzyloxy)phenyl](2H3)ethanone

1-[3,4-Bis(benzyloxy)phenyl](2H3)ethanone

C22H17D3O3 (335.16006853399995)


   

Boc-(R)-3-AMino-4-(4-tert-butyl-phenyl)-butyric acid

Boc-(R)-3-AMino-4-(4-tert-butyl-phenyl)-butyric acid

C19H29NO4 (335.20964740000005)


   
   

(S)-5-[(Biphenyl-4-yl)methyl]-1-(2,2-dimethylpropionyl)pyrrolidin-2-one

(S)-5-[(Biphenyl-4-yl)methyl]-1-(2,2-dimethylpropionyl)pyrrolidin-2-one

C22H25NO2 (335.188519)


   

Valsartan EP impurity 7

Valsartan EP impurity 7

C19H21N5O (335.1746016)


   

9,9-dimethyl-N-(naphthalen-2-yl)-9H-fluoren-2-amine

9,9-dimethyl-N-(naphthalen-2-yl)-9H-fluoren-2-amine

C25H21N (335.16739060000003)


   

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

C24H17NO (335.1310072)


   

O-(Phenylmethyl)-L-threonine phenylmethyl ester hydrochloride

O-(Phenylmethyl)-L-threonine phenylmethyl ester hydrochloride

C18H22ClNO3 (335.1288132000001)


   

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

C24H17NO (335.1310072)


   

4-(3-(tert-butoxycarbonyl(cyclopropyl)aMino)propoxy)phenylboronic acid

4-(3-(tert-butoxycarbonyl(cyclopropyl)aMino)propoxy)phenylboronic acid

C17H26BNO5 (335.1903936)


   

4-(4,4-Difluoro-1,3,5,7-tetraMethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)-butyric Acid

4-(4,4-Difluoro-1,3,5,7-tetraMethyl-4-bora-3a,4a-diaza-s-indacene-8-yl)-butyric Acid

C17H22BF2N2O2 (335.1742306)


   
   

L-Arginine β-naphthylamide hydrochloride

L-Arginine β-naphthylamide hydrochloride

C16H22ClN5O (335.1512792)


   

ML-167

(5-(4-(((5-Methylfuran-2-yl)methyl)amino)quinazolin-6-yl)furan-2-yl)methanol

C19H17N3O3 (335.12698520000004)


   

(9H-FLUOREN-9-YL)METHYL (4-OXOCYCLOHEXYL)CARBAMATE

(9H-FLUOREN-9-YL)METHYL (4-OXOCYCLOHEXYL)CARBAMATE

C21H21NO3 (335.15213560000007)


   

9-(2-ETHYLHEXYL)CARBAZOLE-3 6-DICARBOXA&

9-(2-ETHYLHEXYL)CARBAZOLE-3 6-DICARBOXA&

C22H25NO2 (335.188519)


   
   
   

Boxidine

1-[2-[4-[4-(trifluoromethyl)phenyl]phenoxy]ethyl]pyrrolidine

C19H20F3NO (335.14969060000004)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

   
   
   

4-CYANOPHENYL 4-OCTYLBENZOATE

4-CYANOPHENYL 4-OCTYLBENZOATE

C22H25NO2 (335.188519)


   

tert-Butyl 4-(((2-nitrophenyl)amino)methyl)piperidine-1-carboxylate

tert-Butyl 4-(((2-nitrophenyl)amino)methyl)piperidine-1-carboxylate

C17H25N3O4 (335.184497)


   

1-(9-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

1-(9-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

C23H17N3 (335.1422402)


   

6-Hydroxy-5-undecyl-4,7-benzothiazoledione

6-Hydroxy-5-undecyl-4,7-benzothiazoledione

C18H25NO3S (335.15550600000006)


   
   

N-(4,4-Diphenyl-3-butenyl)nipecotic acid

N-(4,4-Diphenyl-3-butenyl)nipecotic acid

C22H25NO2 (335.188519)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents

   
   
   

GLYCYL-leucyl-phenylalanine

GLYCYL-leucyl-phenylalanine

C17H25N3O4 (335.184497)


   

Coumarin, 7-hydroxy-4-phenyl-8-(piperidinomethyl)-

Coumarin, 7-hydroxy-4-phenyl-8-(piperidinomethyl)-

C21H21NO3 (335.15213560000007)


   

N-tetradecanoyltaurine

N-tetradecanoyltaurine

C16H33NO4S (335.21301780000005)


A fatty acid-taurine conjugate derived from tetradecanoic acid.

   

4-Ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

4-Ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   
   

(2S)-2-[[2-[[(2S)-2-amino-4-methylpentanoyl]amino]acetyl]amino]-3-phenylpropanoic acid

(2S)-2-[[2-[[(2S)-2-amino-4-methylpentanoyl]amino]acetyl]amino]-3-phenylpropanoic acid

C17H25N3O4 (335.184497)


   

6-(4-benzylpiperidin-1-yl)-N-cyclopropylpyridine-3-carboxamide

6-(4-benzylpiperidin-1-yl)-N-cyclopropylpyridine-3-carboxamide

C21H25N3O (335.199752)


   

6-Amino-4-[2-(4-methoxyphenyl)ethyl]-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

6-Amino-4-[2-(4-methoxyphenyl)ethyl]-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

C18H17N5O2 (335.1382182)


   

(3r,4s)-1-[(4-Amino-5h-Pyrrolo[3,2-D]pyrimidin-7-Yl)methyl]-4-[(Butylsulfanyl)methyl]pyrrolidin-3-Ol

(3r,4s)-1-[(4-Amino-5h-Pyrrolo[3,2-D]pyrimidin-7-Yl)methyl]-4-[(Butylsulfanyl)methyl]pyrrolidin-3-Ol

C16H25N5OS (335.177972)


   

3-{[(9-Cyano-9,10-dihydro-10-methylacridin-9-YL)carbonyl]amino}propanoic acid

3-{[(9-Cyano-9,10-dihydro-10-methylacridin-9-YL)carbonyl]amino}propanoic acid

C19H17N3O3 (335.12698520000004)


   

2-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-6-(cyclopentyloxy)benzenolate

2-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-6-(cyclopentyloxy)benzenolate

C20H21N3O2 (335.1633686)


   

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

C16H21N3O3S (335.13035560000003)


   

3-[4-(1-Formylpiperazin-4-yl)-benzylidenyl]-2-indolinone

3-[4-(1-Formylpiperazin-4-yl)-benzylidenyl]-2-indolinone

C20H21N3O2 (335.1633686)


   

Bis(5-amidino-benzimidazolyl)methane

Bis(5-amidino-benzimidazolyl)methane

C17H19N8+3 (335.1732594)


   

Myristyltrimethylammonium bromide

Tetradecyltrimethylammonium bromide

C17H38BrN (335.2187448)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AC - Medicated shampoos C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents

   

2-(4-Methoxyphenyl)-1-(1-pentylindol-3-YL)ethanone

2-(4-Methoxyphenyl)-1-(1-pentylindol-3-YL)ethanone

C22H25NO2 (335.188519)


   

N-[1-(3-methylbenzyl)-1H-pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

N-[1-(3-methylbenzyl)-1H-pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

C19H17N3O3 (335.12698520000004)


   

3-[1-(4-Carbamimidoylphenyl)triazol-4-yl]-4-methoxybenzenecarboximidamide

3-[1-(4-Carbamimidoylphenyl)triazol-4-yl]-4-methoxybenzenecarboximidamide

C17H17N7O (335.1494512)


   

4-[[3-(4-phenoxyphenyl)-1H-pyrazol-5-yl]methyl]morpholine

4-[[3-(4-phenoxyphenyl)-1H-pyrazol-5-yl]methyl]morpholine

C20H21N3O2 (335.1633686)


   

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol

C22H25NO2 (335.188519)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D020011 - Protective Agents > D000975 - Antioxidants D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

C12H21N3O8 (335.1328586)


Zwitterionic form of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

leukotriene B4(1-)

leukotriene B4(1-)

C20H31O4- (335.2222226)


The leukotriene anion that is the conjugate base of leukotriene B4 arising from deprotonation of the carboxylic acid function.

   
   

(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate

(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,10E,12S,14Z)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate

(5Z,8Z,10E,12S,14Z)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate

C20H31O4- (335.2222226)


   

15(S)-Hpete(1-)

15(S)-Hpete(1-)

C20H31O4- (335.2222226)


Conjugate base of 15(S)-HPETE arising from deprotonation of the carboxylic acid function.

   

(5Z,9E,14Z)-(8XI,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate

(5Z,9E,14Z)-(8XI,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate

C20H31O4- (335.2222226)


Conjugate base of (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic acid arising from deprotonation of the carboxylic acid function.

   

(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate

(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8R,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate

(5Z,8R,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate

(5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate

C20H31O4- (335.2222226)


   

15(R)-Hpete(1-)

15(R)-Hpete(1-)

C20H31O4- (335.2222226)


A hydroperoxy fatty acid anion that is the conjugate base of 15(R)-HPETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoate

(8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoate

(8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoate

(10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   
   

(13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-Oate

(13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-Oate

C20H31O4- (335.2222226)


   

Diaminobutyryl-citryl-ethanolamine

Diaminobutyryl-citryl-ethanolamine

C12H21N3O8 (335.1328586)


   

(2R,3S,9R)-5-acetyl-8,8-dimethyl-6-oxo-7,16-diazapentacyclo[9.6.1.02,9.03,7.015,18]octadeca-1(17),4,11(18),12,14-pentaen-4-olate

(2R,3S,9R)-5-acetyl-8,8-dimethyl-6-oxo-7,16-diazapentacyclo[9.6.1.02,9.03,7.015,18]octadeca-1(17),4,11(18),12,14-pentaen-4-olate

C20H19N2O3- (335.13956040000005)


   

(1R,4Z,6R,7R)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

(1R,4Z,6R,7R)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   

Strychnine(1+)

Strychnine(1+)

C21H23N2O2+ (335.17594379999997)


An indole alkaloid cation obtained by protonation of the tertiary amino group of strychnine.

   
   

7-[(1R,2S)-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate

7-[(1R,2S)-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate

C20H31O4- (335.2222226)


   

(13E)-(15S)-15-Hydroxy-9-oxoprosta-11,13-dienoate

(13E)-(15S)-15-Hydroxy-9-oxoprosta-11,13-dienoate

C20H31O4- (335.2222226)


   

(5Z,8Z,14Z)-(11R,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoate

(5Z,8Z,14Z)-(11R,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoate

C20H31O4- (335.2222226)


   

(5S,7E,9E,11Z,13E,15S)-5,15-dihydroxyicosa-7,9,11,13-tetraenoate

(5S,7E,9E,11Z,13E,15S)-5,15-dihydroxyicosa-7,9,11,13-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,11Z,14Z)-(8S,9S,10R)-10-hydroxy-8,9-epoxyicosa-5,11,14-trienoate

(5Z,11Z,14Z)-(8S,9S,10R)-10-hydroxy-8,9-epoxyicosa-5,11,14-trienoate

C20H31O4- (335.2222226)


   

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

C12H21N3O8 (335.1328586)


   

Pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl(1,6)dioxacyclododecino(2,3,4-gh)-

Pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl(1,6)dioxacyclododecino(2,3,4-gh)-

C18H25NO5 (335.173264)


D000970 - Antineoplastic Agents

   

Neo-triangularine

Neo-triangularine

C18H25NO5 (335.173264)


   
   
   

Pyridinopyrone C

Pyridinopyrone C

C21H21NO3 (335.15213560000007)


A natural product found in Streptomyces species.

   

Pyridinopyrone B

Pyridinopyrone B

C21H21NO3 (335.15213560000007)


A natural product found in Streptomyces species.

   

prostaglandin A1(1-)

prostaglandin A1(1-)

C20H31O4- (335.2222226)


Conjugate base of prostaglandin A1.

   

(5as,12as,13as)-12,12-Dimethyl-2,3,11,12,12a,13-Hexahydro-1h,5h,6h-5a,13a-(Epiminomethano)indolizino[7,6-B]carbazol-14-One

(5as,12as,13as)-12,12-Dimethyl-2,3,11,12,12a,13-Hexahydro-1h,5h,6h-5a,13a-(Epiminomethano)indolizino[7,6-B]carbazol-14-One

C21H25N3O (335.199752)


   

Thr-Thr-Asp

Thr-Thr-Asp

C12H21N3O8 (335.1328586)


A tripeptide composed of two L-threonine units and L-aspartic acid joined by peptide linkages.

   
   

4-methyl-N-[(2-methylquinolin-4-yl)methyl]-3-nitrobenzamide

4-methyl-N-[(2-methylquinolin-4-yl)methyl]-3-nitrobenzamide

C19H17N3O3 (335.12698520000004)


   

Prostaglandin C1(1-)

Prostaglandin C1(1-)

C20H31O4- (335.2222226)


Conjugate base of prostaglandin C1.

   

4-[[6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-yl]amino]benzoic acid methyl ester

4-[[6-methyl-2-(6-oxo-1-cyclohexa-2,4-dienylidene)-1H-pyrimidin-4-yl]amino]benzoic acid methyl ester

C19H17N3O3 (335.12698520000004)


   

5-Hpete(1-)

5-Hpete(1-)

C20H31O4- (335.2222226)


A HPETE anion that is the conjugate base of 5-HPETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

15-Hpete(1-)

15-Hpete(1-)

C20H31O4- (335.2222226)


A HPETE anion that is the conjugate base of 15-HPETE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

5-[(3-Methylanilino)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

5-[(3-Methylanilino)methylidene]-1-(2-methylphenyl)-1,3-diazinane-2,4,6-trione

C19H17N3O3 (335.12698520000004)


   

5-(2-hydroxy-3,5-dimethylphenyl)-N-(4-methylbenzyl)-1H-pyrazole-3-carboxamide

5-(2-hydroxy-3,5-dimethylphenyl)-N-(4-methylbenzyl)-1H-pyrazole-3-carboxamide

C20H21N3O2 (335.1633686)


   

2-[[anilino(oxo)methyl]amino]-N-(2-furanylmethyl)benzamide

2-[[anilino(oxo)methyl]amino]-N-(2-furanylmethyl)benzamide

C19H17N3O3 (335.12698520000004)


   

5(S),15(S)-DiHETE(1-)

5(S),15(S)-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 5(S),15(S)-DiHETE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5(S),11(R)-DiHETE(1-)

5(S),11(R)-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 5(S),11(R)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5(S),15(R)-DiHETE(1-)

5(S),15(R)-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 5(S),15(R)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

4-[3-(4-Methoxyanilino)-3-oxopropyl]-1-piperazinecarboxylic acid ethyl ester

4-[3-(4-Methoxyanilino)-3-oxopropyl]-1-piperazinecarboxylic acid ethyl ester

C17H25N3O4 (335.184497)


   

l-Prolyl-glycyl-l-tyrosine

l-Prolyl-glycyl-l-tyrosine

C16H21N3O5 (335.1481136)


   
   
   
   

hepoxilin A3(1-)

hepoxilin A3(1-)

C20H31O4- (335.2222226)


A hepoxilin anion that is the conjugate base of hepoxilin A3, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

hepoxilin B3(1-)

hepoxilin B3(1-)

C20H31O4- (335.2222226)


A hepoxilin anion that is the conjugate base of hepoxilin B3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8S)-hepoxilin A3(1-)

(8S)-hepoxilin A3(1-)

C20H31O4- (335.2222226)


A hepoxilin A3 anion that is the conjugate base of (8S)-hepoxilin A3, obtained by deprotonation of the carboxylic acid group; major species at pH 7.3.

   

4-[1-[(3-Methoxy-4-methylphenyl)methyl]-2-benzimidazolyl]-1,2,5-oxadiazol-3-amine

4-[1-[(3-Methoxy-4-methylphenyl)methyl]-2-benzimidazolyl]-1,2,5-oxadiazol-3-amine

C18H17N5O2 (335.1382182)


   

6-trans-leukotriene B4(1-)

6-trans-leukotriene B4(1-)

C20H31O4- (335.2222226)


A leukotriene anion that is the conjugate base of 6-trans-leukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

1-[(4-Tert-butylphenyl)methyl]-4-(4-nitrophenyl)imidazole

1-[(4-Tert-butylphenyl)methyl]-4-(4-nitrophenyl)imidazole

C20H21N3O2 (335.1633686)


   

8,20-DiHETE(1-)

8,20-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 8,20-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

5,20-DiHETE(1-)

5,20-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 5,20-DiHETE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

9(R)-Hpete(1-)

9(R)-Hpete(1-)

C20H31O4- (335.2222226)


A HPETE anion obtained by deprotonation of the carboxy group of 9(R)-HPETE; major species at pH 7.3.

   

12,20-DiHETE(1-)

12,20-DiHETE(1-)

C20H31O4- (335.2222226)


An icosanoid anion that is the conjugate base of 12,20-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propyl-2-pyridinecarboxamide

N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propyl-2-pyridinecarboxamide

C20H21N3O2 (335.1633686)


   

5-(4-Methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile

5-(4-Methoxyanilino)-2-[(3-methylphenoxy)methyl]-4-oxazolecarbonitrile

C19H17N3O3 (335.12698520000004)


   

2-(7-Oxo-7-phenylheptyl)isoindoline-1,3-dione

2-(7-Oxo-7-phenylheptyl)isoindoline-1,3-dione

C21H21NO3 (335.15213560000007)


   

N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propan-2-yl-4-pyridinecarboxamide

N-[(7-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-propan-2-yl-4-pyridinecarboxamide

C20H21N3O2 (335.1633686)


   

11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1-)

11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1-)

C20H31O4- (335.2222226)


An hepoxilin anion that is the conjugate base of 11(S)-hydroxy-14(S),15(S)-hepoxilin A3, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(2R)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

(2R)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

C18H22ClNO3 (335.1288132000001)


   

(8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoate

(8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoate

(7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoate

C20H31O4- (335.2222226)


A polyunsaturated fatty acid anion that is the conjugate base of (7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoate

(13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoate

C20H31O4- (335.2222226)


An unsaturated fatty acid anion that is the conjugate base of (13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoic acid, obtained by deprotonation of the carboxy group.

   

(1Z)-1-[(6aR,11aS,11bR)-7,7-dimethyl-9,11-dioxo-2,6a,7,11,11a,11b-hexahydro-6H-pyrrolo[1,2:2,3]isoindolo[4,5,6-cd]indol-10(9H)-ylidene]ethanolate

(1Z)-1-[(6aR,11aS,11bR)-7,7-dimethyl-9,11-dioxo-2,6a,7,11,11a,11b-hexahydro-6H-pyrrolo[1,2:2,3]isoindolo[4,5,6-cd]indol-10(9H)-ylidene]ethanolate

C20H19N2O3- (335.13956040000005)


   

N-[(1E)-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]-3-fluorobenzohydrazide

N-[(1E)-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]-3-fluorobenzohydrazide

C20H18FN3O (335.143383)


   

(5Z,8Z,11R,12E,14Z)-11-hydroperoxyicosa-5,8,12,14-tetraenoate

(5Z,8Z,11R,12E,14Z)-11-hydroperoxyicosa-5,8,12,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,11Z,13S)-13-hydroxy-13-[(2S,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z,13S)-13-hydroxy-13-[(2S,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222226)


   
   
   
   

12-oxo-(5S)-Hydroxy-(6Z,8E,14Z)-eicosatrienoate

12-oxo-(5S)-Hydroxy-(6Z,8E,14Z)-eicosatrienoate

C20H31O4- (335.2222226)


   

(5S,6E,10E,12E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

(5S,6E,10E,12E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,11Z)-13-[3-(5-hydroxypentyl)oxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-[3-(5-hydroxypentyl)oxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222226)


   

(S)-3-{[2-(1,1-dimethylallyl)-indol-3-yl]methyl}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one

(S)-3-{[2-(1,1-dimethylallyl)-indol-3-yl]methyl}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one

C21H25N3O (335.199752)


   

(5Z,8S,9E,11Z,13E,15S)-8,15-dihydroxyicosa-5,9,11,13-tetraenoate

(5Z,8S,9E,11Z,13E,15S)-8,15-dihydroxyicosa-5,9,11,13-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,11Z)-13-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate

C20H31O4- (335.2222226)


   

(5Z)-7-{3-[(2Z,5Z)-11-hydroxyundeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoate

(5Z)-7-{3-[(2Z,5Z)-11-hydroxyundeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoate

C20H31O4- (335.2222226)


   

(5Z,8Z)-10-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate

(5Z,8Z)-10-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate

C20H31O4- (335.2222226)


   

(5S,6R,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

(5S,6R,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

C20H31O4- (335.2222226)


   
   
   
   
   
   
   
   
   
   
   
   
   

N-[(E)-(1-methylindol-3-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

N-[(E)-(1-methylindol-3-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C19H17N3O3 (335.12698520000004)


   

(2S)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

(2S)-heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate

C18H22ClNO3 (335.1288132000001)


   

4-[4-[(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

4-[4-[(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-3-azetidinyl]phenyl]-N,N-dimethylbenzamide

C20H21N3O2 (335.1633686)


   

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C18H29N3O3 (335.22088040000006)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(5Z,8Z,10E,12E,14R,15S)-14,15-dihydroxyicosa-5,8,10,12-tetraenoate

(5Z,8Z,10E,12E,14R,15S)-14,15-dihydroxyicosa-5,8,10,12-tetraenoate

C20H31O4- (335.2222226)


   

(5Z,8Z,11Z)-13-hydroxy-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoate

(5Z,8Z,11Z)-13-hydroxy-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoate

C20H31O4- (335.2222226)


   

3-(1H-indol-3-yl)-2-[[(Z)-3-pyridin-2-ylprop-2-enoyl]amino]propanoic acid

3-(1H-indol-3-yl)-2-[[(Z)-3-pyridin-2-ylprop-2-enoyl]amino]propanoic acid

C19H17N3O3 (335.12698520000004)


   
   

Ethyl (Z)-2-cyano-3-(2-piperidin-1-ylquinolin-3-yl)prop-2-enoate

Ethyl (Z)-2-cyano-3-(2-piperidin-1-ylquinolin-3-yl)prop-2-enoate

C20H21N3O2 (335.1633686)


   

2-(1H-benzimidazol-2-yl)-4-(3,4-dimethoxyphenyl)-3-oxobutanenitrile

2-(1H-benzimidazol-2-yl)-4-(3,4-dimethoxyphenyl)-3-oxobutanenitrile

C19H17N3O3 (335.12698520000004)


   

(5Z,8Z,12E)-11-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,12-trienoate

(5Z,8Z,12E)-11-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,12-trienoate

C20H31O4- (335.2222226)


   

4-{3-[(2Z,5Z,8Z)-14-hydroxytetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoate

4-{3-[(2Z,5Z,8Z)-14-hydroxytetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoate

C20H31O4- (335.2222226)


   

(5S,6S,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

(5S,6S,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate

C20H31O4- (335.2222226)


   

4-[(Z)-[(2,6-dimethylquinolin-4-yl)hydrazinylidene]methyl]-2-ethoxyphenol

4-[(Z)-[(2,6-dimethylquinolin-4-yl)hydrazinylidene]methyl]-2-ethoxyphenol

C20H21N3O2 (335.1633686)


   

2-(1,1-Dimethyl-2-propenyl)-3-(1-hydroxy-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-3-ylmethyl)-1H-indole

2-(1,1-Dimethyl-2-propenyl)-3-(1-hydroxy-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-3-ylmethyl)-1H-indole

C21H25N3O (335.199752)


   
   

4-Benzoyl-2,6-diphenylpyridine

4-Benzoyl-2,6-diphenylpyridine

C24H17NO (335.1310072)


   

N-Acetylglycylphenylalanylglycine methyl ester

N-Acetylglycylphenylalanylglycine methyl ester

C16H21N3O5 (335.1481136)


   

N-Acetyl-glycyl-phenylalanyl-glycine methylester

N-Acetyl-glycyl-phenylalanyl-glycine methylester

C16H21N3O5 (335.1481136)


   

6-Methoxy-3-methyl-9-[2-(6-methylpyridin-3-yl)ethyl]-1,2,3,4-tetrahydro-gamma-carboline

6-Methoxy-3-methyl-9-[2-(6-methylpyridin-3-yl)ethyl]-1,2,3,4-tetrahydro-gamma-carboline

C21H25N3O (335.199752)


   

2-Benzyl-4-methyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

2-Benzyl-4-methyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

C19H17N3O3 (335.12698520000004)


   

naratriptan

naratriptan

C17H25N3O2S (335.166739)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

N-Acetylglucosaminylasparagine

N(4)-(beta-N-Acetyl-D-glucosaminyl)-L-asparagine

C12H21N3O8 (335.1328586)


An N(4)-glycosyl-L-asparagine having (beta-N-acetyl-D-glucosaminyl as the glycosyl component.

   

MTAB

Tetradecyltrimethylammonium bromide

C17H38N. Br (335.2187448)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AC - Medicated shampoos C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents Same as: D02164

   

5(S)-HPETE(1-)

5(S)-HPETE(1-)

C20H31O4 (335.2222226)


Conjugate base of 5(S)-HPETE arising from deprotonation of the carboxylic acid function.

   

8(R)-HPETE(1-)

8(R)-HPETE(1-)

C20H31O4 (335.2222226)


Conjugate base of 8(R)-HPETE arising from deprotonation of the carboxylic acid function.

   

Dansylcadaverine

Dansylcadaverine

C17H25N3O2S (335.166739)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   
   

2-[6-(Cyclopentylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[6-(Cyclopentylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O4 (335.15934660000005)


   

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

N-2-[4-(3,3-Dimethylallyloxy)phenyl]ethylcinnamide

C22H25NO2 (335.188519)


   

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate

C20H31O4 (335.2222226)


   

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate

C20H31O4 (335.2222226)


   

8(S),15(S)-DiHETE(1-)

8(S),15(S)-DiHETE(1-)

C20H31O4 (335.2222226)


A DiHETE(1-) that is the conjugate base of 8(S),15(S)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

alpha-cyclopiazonate

alpha-cyclopiazonate

C20H19N2O3 (335.13956040000005)


An organic anion that is the conjugate base of alpha-cyclopiazonic acid; major species at pH 7.3.

   

N(6)-(delta(2)-Isopentenyl)adenosine

N(6)-(delta(2)-Isopentenyl)adenosine

C15H21N5O4 (335.15934660000005)


A nucleoside analogue in which adenosine has been modified by substitution at the 6-amino nitrogen by a Delta(2)-isopentenyl group.

   

AcCa(12:4)

AcCa(12:4)

C19H29NO4 (335.20964740000005)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine

C18H22ClNO3 (335.1288132000001)


   
   
   
   
   
   
   
   

AMPA receptor modulator-3

AMPA receptor modulator-3

C18H22FNO2S (335.1355204)


AMPA receptor modulator-3 is an allosteric AMPA receptor modulator (EC50: 4.4 μM). AMPA receptor modulator-3 can be used in the research of mammalian nervous system, such as learning and memory[1][2].

   

Longdaysin

Longdaysin

C16H16F3N5 (335.1357732)


Longdaysin is a inhibitor of the Wnt/β-catenin signaling pathway, which exerts antitumor effect through blocking CK1δ/ε-dependent Wnt signaling. Longdaysin inhibits CK1α, CK1δ, CDK7, and ERK2 with IC50s of? 5.6 μM, 8.8 μM, 29 μM, and 52 μM, respectively[1][2].

   

NL-1

NL-1

C18H25NO3S (335.15550600000006)


NL-1 is a mitoNEET inhibitor with antileukemic effect. NL-1 inhibits REH and REH/Ara-C cells growth with IC50s of 47.35 μM and 56.26 μM, respectively. NL-1-mediated death in leukemic cells requires the activation of the autophagic pathway[1].

   

PPARγ-IN-2

PPARγ-IN-2

C19H21N5O (335.1746016)


PPARγ-IN-2 (Compound 5a) is a PPARγ inhibitor. PPARγ-IN-2 inhibits TG accumulation in 3T3-L1 preadipocytes (EC50: 0.106 μM). PPARγ-IN-2 inhibits high-cholesterol diet (HFC)-induced obesity and related metabolic syndrome, and reduces lipid accumulation in adipose tissue[1].

   

VU0364289

VU0364289

C20H21N3O2 (335.1633686)


VU0364289 is a highly selective mGlu5 positive allosteric modulator (PAM) (binds to the MPEP (HY-14609A) site), with an EC50 of 1.6 μM. VU0364289 can reverse amphetamine-induced hyperlocomotion in a dose-dependent manner, which can be used for schizophrenia and other psychiatric research[1][2][3].

   

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-8-carboxylic acid

5-(3-amino-3-carboxypropyl)-1h,2h,3h,8h,9h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-8-carboxylic acid

C17H25N3O4 (335.184497)


   

5-(1-aminoethylidene)-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraene-4,6-dione

5-(1-aminoethylidene)-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-1(17),11(18),12,14-tetraene-4,6-dione

C20H21N3O2 (335.1633686)


   

2-{2-[1-(dimethylamino)-2-phenylethyl]-1,3-oxazole-5-carbonyl}aniline

2-{2-[1-(dimethylamino)-2-phenylethyl]-1,3-oxazole-5-carbonyl}aniline

C20H21N3O2 (335.1633686)


   

(2r,3s,5r)-5-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

(2r,3s,5r)-5-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol

C15H21N5O4 (335.15934660000005)


   

(1r,4e,6s,7r,17s)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1r,4e,6s,7r,17s)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)


   

(1'r,2r,4s,4'r,7's)-4-methyl-4'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-11'-oxa-5'-azaspiro[oxolane-2,10'-tricyclo[5.3.1.0¹,⁵]undecan]-5-one

(1'r,2r,4s,4'r,7's)-4-methyl-4'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-11'-oxa-5'-azaspiro[oxolane-2,10'-tricyclo[5.3.1.0¹,⁵]undecan]-5-one

C18H25NO5 (335.173264)


   

(1s,13s,15s)-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s)-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C21H25N3O (335.199752)


   

5-{5-[(acetyloxy)methyl]-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methyl-4-oxopent-2-enimidic acid

5-{5-[(acetyloxy)methyl]-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl}-2-methyl-4-oxopent-2-enimidic acid

C18H25NO5 (335.173264)


   

(1r,4r,5s)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hexyl-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(1r,4r,5s)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hexyl-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C19H29NO4 (335.20964740000005)


   

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

C16H21N3O3S (335.13035560000003)


   

2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.13688060000004)


   

(1r,4e,7r,11s,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

(1r,4e,7r,11s,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,8-dione

C18H25NO5 (335.173264)


   

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.13035560000003)


   

(4e)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(4e)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H25NO5 (335.173264)